Brief: Elevai Labs says Nasdaq Grants Co Exception To Cure Bid Price Deficiency
Nov 13 (Reuters) - Elevai Labs Inc ELAB.O :
* ELEVAI LABS INC: NASDAQ GRANTS ELEVAI LABS EXCEPTION TO
CURE BID
PRICE DEFICIENCY
* ELEVAI LABS INC: REQUIRED TO NOTIFY NASDAQ OF SIGNIFICANT
EVENTS
UNTIL JAN 9, 2025
Further company coverage: ELAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PMGC Holdings
See all newsBrief: PMGC Holdings Signs Non-Binding Letter Of Intent To Acquire Majority Stake In US-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, And Semiconductor Markets
Brief: PMGC Holdings Offers $7.8 Million In Common Stock To Streeterville Capital
NASDAQ RESUMED AT 12:33 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:28 PM
NASDAQ RESUMED AT 09:46 AM